An epidemic of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease, or NAFLD, is the 21st century epidemic in liver disease according to Dr. Zobair Younossi speaking at the annual meeting of the American College of Physicians in New Orleans. Also today, how smoking and drinking impact risk for SLE among black women in the U.S., the FDA approves the first EpiPen generic, and final 15-year data from the veterans affairs diabetes trial. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa

Apple Podcasts

Spotify